Itolizumab
-
Covid-19: Cytokine Storm and Itolizumab’s Hurried Breakthrough Affair in India
Is cytokine storm misleading in Covid-19 and should immunomodulator drugs be used as therapies? Although the SARS-CoV-2 virus primarily affects…
Read More » -
Biocon’s Psoriasis Drug Itolizumab Receives DCGI Nod for Emergency Use in Covid-19
Bengaluru: Biocon, the global biopharmaceuticals company, has said that it has received the Drugs Controller General of India’s (DCGI) approval…
Read More »